Tirzepatide
Tirzepatide
Couldn't load pickup availability
For laboratory research use only. Not for human or veterinary use.
Prysm Peptides’ Tirzepatide is a synthetic research peptide that activates glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.
This dual receptor profile is studied in incretin biology and metabolic signaling research. The product is available in two vial sizes for laboratory and analytical work.
Formulation Details
| Property | Details |
|---|---|
| Compound | Tirzepatide |
| Product identifier | Tirzepatide |
| Amount per vial | 20 mg or 30 mg, depending on selected variant |
| Receptor profile | GIP and GLP-1 receptor agonist |
The cited prescription-product information describes the molecule; it does not establish equivalence between this research material and a prescription formulation.
Research Context
- GIP and GLP-1 receptor activation.
- Incretin-associated metabolic signaling.
- Comparative receptor and peptide characterization studies.
These topics describe published research on the compound or its individual components and do not establish performance in a particular experimental system.
Storage & Handling
Follow the product label and supplier documentation for storage temperature, handling conditions, and any applicable stability limits. Use appropriate laboratory protective equipment and procedures. Solution preparation and storage should follow a validated protocol appropriate to the supplied formulation.
Scientific References
Research Notice
This product is intended exclusively for laboratory and analytical research purposes. This product is not intended for human or veterinary use, consumption, treatment, diagnosis, or any clinical application. Purchase constitutes acknowledgment of intended research use only.
